Comirnaty

Pharma

BioNTech's COVID vaccine sales surpassed expectations in Q3

Despite surprisingly high sales of its COVID-19 vaccine, BioNTech said it to expects annual sales to be at the low end of its revenue guidance window.

Kevin Dunleavy Nov 4, 2024 11:32am

Penn sues BioNTech over Comirnaty royalties

Aug 7, 2024 7:30am

BioNTech posts €808M loss as it grapples with seasonal vaccines

Aug 5, 2024 10:56am

Kansas AG sues Pfizer for allegedly covering up Comirnaty risks

Jun 18, 2024 2:00pm

BioNTech, CEPI amp up mRNA vaccine activity in Africa

May 30, 2024 9:11am

investment money shot vaccine pharma dollar

The top 20 drugs by 2023 sales

May 28, 2024 3:00am